Safety and efficacy of tolcapone in Parkinson’s disease: systematic review

PURPOSE: Tolcapone is an efficacious catechol-O-methyltransferase inhibitor for Parkinson’s disease (PD). However, safety issues hampered its use in clinical practice. We aimed to provide evidence of safety and efficacy of tolcapone by a systematic literature review to support clinicians’ choices in...

Descripción completa

Detalles Bibliográficos
Autores principales: Artusi, Carlo Alberto, Sarro, Lidia, Imbalzano, Gabriele, Fabbri, Margherita, Lopiano, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128808/
https://www.ncbi.nlm.nih.gov/pubmed/33415500
http://dx.doi.org/10.1007/s00228-020-03081-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128808/
https://www.ncbi.nlm.nih.gov/pubmed/33415500
http://dx.doi.org/10.1007/s00228-020-03081-x

Ejemplares similares